loadpatents
Patent applications and USPTO patent grants for ABBOT; Stewart.The latest application filed is for "chimeric antigen receptors".
Patent | Date |
---|---|
Chimeric Antigen Receptors App 20220106404 - ABBOT; Stewart ;   et al. | 2022-04-07 |
Modified T Lymphocytes App 20210299175 - Abbot; Stewart ;   et al. | 2021-09-30 |
Chimeric antigen receptors Grant 11,130,820 - Abbot , et al. September 28, 2 | 2021-09-28 |
Enhanced Placental Stem Cells And Uses Thereof App 20210238544 - Abbot; Stewart ;   et al. | 2021-08-05 |
Modified T lymphocytes comprising a BAFF antibody-inducible caspase and methods of apoptosis Grant 10,967,005 - Abbot , et al. April 6, 2 | 2021-04-06 |
Method Of Producing Erythrocytes App 20210032596 - Heidaran; Mohammad A. ;   et al. | 2021-02-04 |
Methods Of Expanding T Cells App 20200407681 - Abbot; Stewart ;   et al. | 2020-12-31 |
Enhanced placental stem cells and uses thereof Grant 10,329,529 - Abbot , et al. | 2019-06-25 |
Modified T Lymphocytes App 20190175652 - Abbot; Stewart ;   et al. | 2019-06-13 |
Engager Cells For Immunotherapy App 20190117692 - Gottschalk; Stephen M. G. ;   et al. | 2019-04-25 |
Chimeric Antigen Receptors App 20190119399 - Abbot; Stewart ;   et al. | 2019-04-25 |
Modified T lymphocytes comprising an inducible caspase and methods of apoptosis Grant 10,238,690 - Abbot , et al. | 2019-03-26 |
Chimeric antigen receptors Grant 10,150,816 - Abbot , et al. Dec | 2018-12-11 |
Modified T Lymphocytes Having Improved Specificity App 20180273640 - Liang; Bitao ;   et al. | 2018-09-27 |
Method of producing erythrocytes without feeder cells Grant 10,041,043 - Abbot , et al. August 7, 2 | 2018-08-07 |
Angiogenesis Using Placental Stem Cells App 20180071343 - Abbot; Stewart ;   et al. | 2018-03-15 |
Natural killer cells from placenta Grant 9,763,983 - Zhang , et al. September 19, 2 | 2017-09-19 |
Method Of Producing Erythrocytes App 20170240860 - Heidaran; Mohammad A. ;   et al. | 2017-08-24 |
Enhancement Of Placental Stem Cell Potency Using Modulatory Rna Molecules App 20170000828 - Abbot; Stewart ;   et al. | 2017-01-05 |
Method Of Producing Erythrocytes Without Feeder Cells App 20160362659 - Abbot; Stewart ;   et al. | 2016-12-15 |
Amnion Derived Adherent Cells App 20160361366 - Abbot; Stewart ;   et al. | 2016-12-15 |
Methods Of Expanding T Cells App 20160137980 - Abbot; Stewart ;   et al. | 2016-05-19 |
Angiogenesis Using Placental Stem Cells App 20160106784 - Abbot; Stewart ;   et al. | 2016-04-21 |
Angiogenesis using placental stem cells Grant 9,254,302 - Abbot , et al. February 9, 2 | 2016-02-09 |
Method of producing erythrocytes without feeder cells Grant 9,255,248 - Abbot , et al. February 9, 2 | 2016-02-09 |
Modified T Lymphocytes App 20160030479 - Abbot; Stewart ;   et al. | 2016-02-04 |
Engager Cells For Immunotherapy App 20160015749 - Gottschalk; Stephen M. G. ;   et al. | 2016-01-21 |
Enhanced Placental Stem Cells And Uses Thereof App 20160017282 - Abbot; Stewart ;   et al. | 2016-01-21 |
Natural Killer Cells From Placenta App 20150366910 - ZHANG; Xiaokui ;   et al. | 2015-12-24 |
Modified T Lymphocytes Having Improved Specificity App 20150368360 - Liang; Bitao ;   et al. | 2015-12-24 |
Amnion derived adherent cells Grant 9,198,938 - Abbot , et al. December 1, 2 | 2015-12-01 |
Anoikis Resistant Placental Stem Cells And Uses Thereof App 20150307879 - Zhang; Xiaokui ;   et al. | 2015-10-29 |
Chimeric Antigen Receptors App 20150307623 - Abbot; Stewart ;   et al. | 2015-10-29 |
Natural Killer Cells And Uses Thereof App 20150225697 - Law; Eric ;   et al. | 2015-08-13 |
Enhancement Of Placental Stem Cell Potency Using Modulatory Rna Molecules App 20150190434 - Abbot; Stewart ;   et al. | 2015-07-09 |
Modified Erythrocyte Precursor Cells And Uses Thereof App 20150118265 - Edinger; James W. ;   et al. | 2015-04-30 |
Enhancement of placental stem cell potency using modulatory RNA molecules Grant 8,969,315 - Abbot , et al. March 3, 2 | 2015-03-03 |
Method Of Producing Erythrocytes Without Feeder Cells App 20140256042 - Abbot; Stewart ;   et al. | 2014-09-11 |
Amnion Derived Adherent Cells App 20130315875 - Abbot; Stewart ;   et al. | 2013-11-28 |
Method of producing erythrocytes without feeder cells Grant 8,586,360 - Abbot , et al. November 19, 2 | 2013-11-19 |
Amnion derived adherent cells Grant 8,367,409 - Abbot , et al. February 5, 2 | 2013-02-05 |
Enhancement Of Placental Stem Cell Potency Using Modulatory Rna Molecules App 20120230959 - ABBOT; Stewart ;   et al. | 2012-09-13 |
Treatment Of Spinal Cord Injury And Traumatic Brain Injury Using Amnion Derived Adherent Cells App 20120201787 - Abbot; Stewart ;   et al. | 2012-08-09 |
Treatment Of Immune-related Diseases And Disorders Using Amnion Derived Adherent Cells App 20120164114 - Abbot; Stewart ;   et al. | 2012-06-28 |
Treatment Of Spinal Cord Injury And Traumatic Brain Injury Using Placental Stem Cells App 20120156230 - Abbot; Stewart ;   et al. | 2012-06-21 |
Angiogenesis Using Placental Stem Cells App 20110250182 - ABBOT; Stewart ;   et al. | 2011-10-13 |
Method Of Producing Erythrocytes Without Feeder Cells App 20110003387 - Abbot; Stewart ;   et al. | 2011-01-06 |
Amnion Derived Adherent Cells App 20100124569 - ABBOT; Stewart ;   et al. | 2010-05-20 |
SEC | 0001655597 | ABBOT STEWART |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.